The existence of corticosteroid-induced pancreatitis remains controversial, despite the fact that more than 40 cases have been reported since its first description in 1955. No previous case reports have shown recurrence of pancreatitis after rechallenge with corticosteroids. This report describes a patient with stage IIIB Hodgkin's disease who received dexamethasone on three occasions for symptoms of spinal cord compression. On each occasion, the patient developed clinically evident pancreatitis shortly after beginning corticosteroid therapy. We believe that the close temporal relationship of the recurrences following rechallenge clearly implicates corticosteroids as an etiologic factor in this patient's pancreatitis.
Download full-text PDF |
Source |
---|
Ann Med Surg (Lond)
May 2022
Endocrine Unit, Internal Medicine Department, KFMMC, Dhahran, 31932, Saudi Arabia.
Background: Hypertriglyceridemia is a medical condition defined as fasting triglyceride level more than 150 mg/dl. It could be due to either familial or acquired cause as in obesity, metabolic syndrome, diabetes mellitus type 2, alcohol consumption, decrease exercise or drug affects. Drugs such as corticosteroids rarely induced hypertriglyceridemia, for that we are reporting this case.
View Article and Find Full Text PDFRev Med Interne
September 2020
CHU Pitié-Salpêtrière, Service de diabétologie-métabolismes, Assistance Publique Hôpitaux de Paris, Sorbonne Université, Paris, France. Electronic address:
Diabetes frequently occurs during corticosteroid treatment, sometimes necessitating urgent therapeutic management, with insulin for example. Corticosteroids induce insulin resistance in the liver, adipocytes and skeletal muscle, and have direct deleterious effects on insulin secretion. The development of insulin resistance during corticosteroid treatment, and the insufficient adaptation of insulin secretion, are key elements in the pathophysiology of corticosteroid-induced diabetes.
View Article and Find Full Text PDFCureus
July 2020
Internal Medicine, Mather Hospital, Port Jefferson, USA.
Drug-induced pancreatitis is uncommon among all cases of acute pancreatitis in the general population. The majority of reported cases are mild, but severe and even fatal cases have been also reported. Management of corticosteroid-induced acute pancreatitis requires withdrawal of the offending agent and supportive care.
View Article and Find Full Text PDFDrug Saf
December 2007
Department of Internal Medicine, Hôpital Saint Antoine, Paris, France.
Corticosteroids represent the most important and frequently used class of anti-inflammatory drugs and are the reference therapy for numerous neoplastic, immunological and allergic diseases. However, their substantial efficacy is often counter-balanced by multiple adverse events. These corticosteroid-induced adverse events represent a broad clinical and biological spectrum from mild irritability to severe and life-threatening adrenal insufficiency or cardiovascular events.
View Article and Find Full Text PDFDiabetes Metab
December 2006
Service d'Endocrinologie-Métabolisme et Diabétologie-Nutrition, Hôpital Jean Minjoz, CHU de Besançon, F-25030 Besançon Cedex, France.
Post-transplant diabetes mellitus (PTDM) has emerged as a major adverse effect of immunosuppressive drugs (ISD). As recipients of organ transplants survive longer, the complications of diabetes mellitus have assumed greater importance. The predominant factor for causing PTDM by corticosteroids seems to be the aggravation of insulin resistance, however several studies have displayed deleterious effects on insulin secretion and beta-cells.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!